tweetindex
DE

Vincent Rajkumar

@VincentRK · Rochester, MN, USA · joined 13 Mar 2009

Editor-in-Chief, Blood Cancer Journal; Chairman @IMFmyeloma Board; Cancer & Myeloma Research; Opinions solely personal views https://t.co/HOGYJSpsoG

81 559Followers
1 648Following
54 269Posts total
164KViews on collected posts

Neueste Beiträge

@VincentRK @pashtoonkasi @IMFmyeloma @MayoClinic Dr. Bob Kyle was kind, wise and a true gentleman, he has profound influence on generations of plasma cell disorders physicians and researchers (including me). My fondest recent memory of Bob is enjoying home cooking in our kitchen
2.5K views · 43 likes · 8 reposts · 0 replies Open on X →
*sorrow 979 views · 9 likes · 2 reposts · 1 replies Open on X →
Article in @MayoProceedings honoring his legacy. https://t.co/HU4ML0dUnA 2.5K views · 32 likes · 11 reposts · 3 replies Open on X →
Video recognizing Dr. Kyle https://t.co/p27MDmnH9p 4.8K views · 42 likes · 11 reposts · 1 replies Open on X →
Profound sorry that my mentor, friend, and colleague, the legend Bob Kyle passed away. His contributions to patients, medicine, myeloma, @IMFmyeloma @MayoClinic myeloma group, and the institution are monumental. A role model who will be remembered for his integrity and commitment
37K views · 378 likes · 79 reposts · 55 replies Open on X →
Our one stop place to calculate risk stratification of myeloma, smoldering myeloma (SMM), MGUS, amyloidosis and Waldenstrom Macroglobulinemia. @myelomaMD @eamadoutoure Check it out and bookmark! https://t.co/8e2dLjpXZg 18.5K views · 102 likes · 40 reposts · 2 replies Open on X →
We live in an infinite resources scenario mindset despite finite resources. This type of pricing which is all too common for new cancer drugs is not sustainable. 15.6K views · 56 likes · 13 reposts · 15 replies Open on X →
"Rasonque will cost $39,800 for a month’s supply of pills, before customary insurance discounts and rebates, the company said." $39,800 * 12 = $477,600 per year... Before rebates and discounts, which may bring the price down for some insurers. Note that is not an out-of-pocket 37.1K views · 99 likes · 24 reposts · 15 replies Open on X →
Just out! Our ViewPoint in @TheLancetHaem We call for plasma cell leukemia to be considered as high risk myeloma and not as a unique disease. Free Open access Link for limited time. Bookmark. https://t.co/U7iOKpEwuK 12.2K views · 75 likes · 23 reposts · 11 replies Open on X →
@VincentRK @icewatervapour My advice to everyone in academia Don’t do stuff for your CV Don’t do stuff to be well known Do stuff you genuinely are curious about and remember the only thing you are really competing against is yourself from yesterday— and time. If you’re luck 1.4K views · 29 likes · 5 reposts · 1 replies Open on X →
@VincentRK @Dr_AmerZeidan Thanks Vincent. Lovely to see your authenticity and humility first hand last night. Your passion shines through. Thank you 442 views · 3 likes · 0 reposts · 0 replies Open on X →
@VincentRK Quite often, academic medicine sometimes confuses productivity with impact. They’re not always the same. 715 views · 3 likes · 0 reposts · 0 replies Open on X →
These are really challenging times for academic medicine. You have to set your goals. If you want to be at the top of the field what matters is truly enduring contributions that help improve patient outcomes. Visibility, titles, fame are transient. Enduring contributions to your 30.3K views · 251 likes · 42 reposts · 10 replies Open on X →
I would like to share the story of how a patient with cancer came up with the idea for a randomized trial, & how listening to him saved a lot of lives. 1/ In 2002, I had just completed a randomized trial with the notorious drug thalidomide for the cancer, multiple myeloma. 0 views · 5.1K likes · 1.5K reposts · 165 replies Open on X →

Im Vergleich zu Konten gleicher Größe

9 Beiträge aus den letzten 90 Tagen, verglichen mit der Größenklasse 10K–100K Follower. wird weit gezeigt, aber nur wenige dieser Zuschauer reagieren.

Medianaufrufe12 166dieses Konto990Median für 10K–100K
Reichweite, %14.92%dieses Konto3.66%Median für 10K–100K
Interaktion, %1.13%dieses Konto1.61%Median für 10K–100K
KennzahlDieses KontoMedian für 10K–100KVerhältnis
Medianaufrufe pro Beitrag12 16699012.3×
Reichweite (Aufrufe ÷ Follower)14.92%3.66%4.08×
Interaktionsrate1.13%1.61%0.70×

Weitere Konten dieser Größe →   Mit einem anderen Konto vergleichen →   Wie diese Vergleichswerte entstehen →

Growth & engagement

How the posts we collected actually performed: views and reaction rate post by post, what the audience did with them, and where the follower count goes.

Views per post

30.3K29 Apr
715
442
1.4K
12.2K25 Aug
37.1K26 Aug
15.6K27 Aug
18.5K30 Aug
37K4 Sep
4.8K
2.5K
979
2.5K

Last 13 collected posts, oldest on the left. The scale is logarithmic: one post can outrun the rest a hundred times over.

Engagement rate per post

1.04%29 Apr
0.42%
0.68%
2.57%
0.92%25 Aug
0.38%26 Aug
0.56%27 Aug
0.79%30 Aug
1.43%4 Sep
1.13%
1.82%
1.23%
2.04%

Reactions — likes, reposts, replies and quotes — divided by views. Median for 10K–100K accounts is 1.61%.

What the audience does

Likes65.4%1 122 in total
Reposts15.0%258 in total
Replies6.6%114 in total
Quotes2.4%41 in total
Bookmarks10.5%180 in total

Share of every reaction we collected for this account. Replies mean argument, reposts mean endorsement, bookmarks mean the post was worth keeping.

Followers by day

8 Sep

Daily snapshots since 08 Sep 2026; the dashed line is the starting count.

Ähnliche Konten